Aclaris Therapeutics to Participate in the 10th Annual SVB Leerink Global Healthcare Conference
10 February 2021 - 11:00PM
Aclaris Therapeutics, Inc. (NASDAQ: ACRS), a clinical-stage
biopharmaceutical company focused on developing novel drug
candidates for immuno-inflammatory diseases, today announced that
management will participate in a virtual fireside chat at the 10th
Annual SVB Leerink Global Healthcare Conference on Thursday,
February 25, 2021 at 8:00 a.m. ET. Management will be available
February 25th throughout the day for virtual one-on-one meetings.
A live audio webcast of the fireside chat may be accessed
through the “Events” page of the “Investors” section of Aclaris’
website, www.aclaristx.com. The webcast will be archived for at
least 30 days on the Aclaris website.
About Aclaris Therapeutics, Inc.
Aclaris Therapeutics, Inc. is a clinical-stage biopharmaceutical
company developing a pipeline of novel drug candidates to address
the needs of patients with immuno-inflammatory diseases who lack
satisfactory treatment options. The company has a multi-stage
portfolio of drug candidates powered by a robust R&D engine
exploring protein kinase regulation. For additional information,
please visit www.aclaristx.com.
Aclaris Contact
investors@aclaristx.com
Aclaris Therapeutics (NASDAQ:ACRS)
Historical Stock Chart
From Apr 2024 to May 2024
Aclaris Therapeutics (NASDAQ:ACRS)
Historical Stock Chart
From May 2023 to May 2024